Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
William T. Boehm, a director at Neogen Corp (NASDAQ:NEOG), recently acquired 5,000 shares of the company’s common stock. The transaction, which took place on April 24, 2025, was executed at an average price of $5.235 per share, resulting in a total purchase value of $26,175. Following this acquisition, Boehm now holds 36,214 shares in the company.The purchase comes as Neogen’s stock shows signs of recovery, posting an 18% gain over the past week despite being down 62% over the last six months. According to InvestingPro analysis, the company’s current market capitalization stands at $1.1 billion, with the stock trading near its Fair Value. Discover more exclusive insights and 12 additional ProTips for Neogen with an InvestingPro subscription, including comprehensive insider trading analysis in our detailed Pro Research Report.
In other recent news, Neogen Corporation reported its fiscal Q3 2025 earnings, showing an unexpected increase in earnings per share (EPS) to $0.10, which exceeded the forecast of -$0.01. However, the company’s revenue fell short, coming in at $221 million compared to the projected $232.36 million. Neogen has also announced an agreement to sell its cleaners and disinfectants division to Kersia Group for $130 million, with the transaction expected to close in the first quarter of Neogen’s 2026 fiscal year. This move is anticipated to improve Neogen’s profit margins and reduce its net leverage ratio. Guggenheim analysts have adjusted Neogen’s stock price target from $15.00 to $13.00 while maintaining a Buy rating, citing mixed updates from the company, including both positive developments and ongoing challenges. Neogen’s sample collection business is reportedly progressing well, and the Petrifilm product line is set to begin production in the upcoming fall season. However, the company has revised its revenue and EBITDA guidance downward due to a challenging macroeconomic environment. Neogen’s CEO, John Audent, emphasized the company’s strategic focus on food safety diagnostics, despite industry challenges and macroeconomic uncertainties.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.